Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
69M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
-1.9M
-
Total reported value, excl. options
-
$139M
-
Value change
-
-$8.39M
-
Put/Call ratio
-
0.44
-
Number of buys
-
29
-
Number of sells
-
-57
-
Price
-
$4.07
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q2 2022
101 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock as of Q2 2022.
Olema Pharmaceuticals, Inc. - Common Stock (OLMA) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 69M outstanding shares and own 49.6% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.61M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3.32M shares), Fairmount Funds Management LLC (2.67M shares), Cormorant Asset Management, LP (2.08M shares), Vivo Capital, LLC (1.69M shares), CITADEL ADVISORS LLC (1.48M shares), VANGUARD GROUP INC (1.41M shares), BlackRock Inc. (1.31M shares), and MILLENNIUM MANAGEMENT LLC (643K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.